Table 3.
Top 25 genes
| Gene name | Name | Log fold change | FDR-adjusted | Mean FPKM |
|---|---|---|---|---|
| RN7SK | 7SK small nuclear | 0.1 | 1.0 | 22,323.9 |
| RN7SL2 | RNA, 7SL, cytoplasmic 2 | −0.5 | 0.7 | 12,212.2 |
| RN7SL4P | RNA, 7SL, cytoplasmic, pseudogene 1 | −0.6 | 0.6 | 5,813.8 |
| RN7SL1 | RNA, 7SL, cytoplasmic 2 | −1.1 | 0.5 | 3,846.0 |
| ANGPTL7 | Angiopoietin-like 7 | 0.4 | 0.8 | 3,529.0 |
| RNA28S5 | Ribosomal RNA 18S 6 | −0.3 | 0.9 | 3,374.0 |
| RN7SKP255 | 7SK small nuclear pseudogene 255 | 0.1 | 1.0 | 2,898.5 |
| RN7SKP203 | 7SK small nuclear pseudogene 203 | −0.1 | 1.0 | 2,836.7 |
| S100A6 | S100 calcium binding protein A6 | 0.1 | 0.9 | 1,950.3 |
| MALAT1 | Metastasis associated lung adenocarcinoma transcript 1 | 0.0 | 1.0 | 1,801.5 |
| DCN | Decorin | 0.0 | 1.0 | 1,791.5 |
| RN7SL5P | RNA, 7SL, cytoplasmic, pseudogene 2 | −1.3 | 0.4 | 1,774.0 |
| THBS4 | Thrombospondin 4 | −0.8 | 0.6 | 1,368.2 |
| MT-CO1 | Mitochondrial cytochrome c oxidase III | −0.6 | 0.6 | 1,230.9 |
| TMSB10 | Thymosin beta 10 | −0.3 | 0.7 | 1,220.1 |
| ASPN | Asporin | −1.6 | 0.5 | 1,145.3 |
| MMP3 | Matrix metallopeptidase 3 | 2.2 | 0.2 | 1,126.7 |
| RNA18S5 | Ribosomal RNA 28S 5 | −0.2 | 0.9 | 1,125.5 |
| CLU | Clusterin | 0.3 | 0.9 | 1,106.6 |
| MT-ND3 | Mitochondrial NADH dehydrogenase 3 | −0.5 | 0.6 | 1,036.1 |
| LUM | Lumican | 0.0 | 1.0 | 978.9 |
| VIM | Vimentin | 0.2 | 0.9 | 977.1 |
| CILP | Cartilage intermediate layer protein | 0.3 | 0.9 | 920.8 |
| EEF1A1 | Eukaryotic translation elongation factor 1 alpha-like 7 | 0.0 | 1.0 | 891.4 |
| IGFBP6 | Insulin-like growth factor-binding protein 6 | 0.7 | 0.6 | 859.0 |
The table demonstrates the 25 most highly expressed genes in young and old tendon in terms of transcript expression as determined by using fragments per kilobase of exon per million fragments mapped (FPKM). FDR, false discovery rate.